ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	9/51	191/7206	6.21520209301e-06
ko04657	IL-17 signaling pathway	6/51	87/7206	3.03284305168e-05
ko00643	Styrene degradation	2/51	4/7206	0.000292022637849
ko05145	Toxoplasmosis	5/51	126/7206	0.0018631234283
ko04512	ECM-receptor interaction	4/51	79/7206	0.00226249217855
ko04064	NF-kappa B signaling pathway	4/51	96/7206	0.00458036582623
ko04621	NOD-like receptor signaling pathway	5/51	157/7206	0.00482480785003
ko05164	Influenza A	5/51	167/7206	0.00625555181138
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/51	79/7206	0.0181131585596
ko00350	Tyrosine metabolism	2/51	33/7206	0.0225472370332
ko05160	Hepatitis C	4/51	153/7206	0.0225566834737
ko05222	Small cell lung cancer	3/51	89/7206	0.0247653784069
ko05120	Epithelial cell signaling in Helicobacter pylori infection	3/51	92/7206	0.0269859435617
ko04658	Th1 and Th2 cell differentiation	3/51	96/7206	0.0301079153488
ko05132	Salmonella infection	3/51	98/7206	0.03173779028
ko05410	Hypertrophic cardiomyopathy (HCM)	3/51	100/7206	0.0334134230262
ko04623	Cytosolic DNA-sensing pathway	2/51	41/7206	0.033786574489
ko00051	Fructose and mannose metabolism	2/51	42/7206	0.0353180495869
ko05206	MicroRNAs in cancer	4/51	177/7206	0.0359214228376
ko05215	Prostate cancer	3/51	111/7206	0.0434391817874
ko05414	Dilated cardiomyopathy	3/51	112/7206	0.0444177773917
ko04624	Toll and Imd signaling pathway	2/51	49/7206	0.046759640315